{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:23:10Z","timestamp":1794655390482,"version":"4.9.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["DOC 50"],"award-info":[{"award-number":["DOC 50"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BioTechMed-Graz: Flagship Project Secretome; DocAcademy Graz; Land Steiermark; the City of Graz; University of Graz"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The gut microbiome contributes to chronic inflammatory responses in ulcerative colitis (UC), but molecular mechanisms and disease-relevant effectors remain unclear. Here we analyze the pro-inflammatory properties of colonic fluid obtained during colonoscopy from UC and control patients. In patients with UC, we find that the pelletable effector fraction is composed mostly of bacterial extracellular vesicles (BEVs) that exhibit high IgA-levels and incite strong pro-inflammatory responses in IgA receptor-positive (CD89<jats:sup>+<\/jats:sup>) immune cells. Biopsy analyses reveal higher infiltration of CD89<jats:sup>+<\/jats:sup> immune cells in the colonic mucosa from patients with UC than control individuals. Further studies show that IgA-coated BEVs, but not host-derived vesicles nor soluble IgA, are potent activators of pro-inflammatory responses in CD89<jats:sup>+<\/jats:sup> cells. IgA-coated BEVs also exacerbate intestinal inflammation in a dextran sodium sulfate colitis model using transgenic mice expressing human CD89. Our data thus implicate a link between IgA-coated BEVs and intestinal inflammation via CD89<jats:sup>+<\/jats:sup> immune cells, and also hint a potential new therapeutic target for UC.<\/jats:p>","DOI":"10.1038\/s41467-025-59354-5","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T08:49:44Z","timestamp":1745916584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Enrichment of human IgA-coated bacterial vesicles in ulcerative colitis as a driver of inflammation"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8965-6716","authenticated-orcid":false,"given":"Himadri B.","family":"Thapa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina A.","family":"Passegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Fleischhacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3819-4085","authenticated-orcid":false,"given":"Yi-Chi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratchara","family":"Kalawong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Tam-Amersdorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Gerstorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Strahlhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0154-7310","authenticated-orcid":false,"given":"Kristina","family":"Schild-Pr\u00fcfert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2035-1898","authenticated-orcid":false,"given":"Ellen L.","family":"Zechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Blesl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7851-9895","authenticated-orcid":false,"given":"Georg A.","family":"Busslinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7241-0864","authenticated-orcid":false,"given":"Leo","family":"Eberl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1149-4782","authenticated-orcid":false,"given":"Gregor","family":"Gorkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8070-4977","authenticated-orcid":false,"given":"Herbert","family":"Strobl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4566-0806","authenticated-orcid":false,"given":"Christoph","family":"H\u00f6genauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7842-0177","authenticated-orcid":false,"given":"Stefan","family":"Schild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"59354_CR1","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/ibd.22839","volume":"18","author":"J Torres","year":"2012","unstructured":"Torres, J., Billioud, V., Sachar, D. B., Peyrin-Biroulet, L. & Colombel, J. F. Ulcerative colitis as a progressive disease: the forgotten evidence. Inflamm. Bowel Dis. 18, 1356\u20131363 (2012).","journal-title":"Inflamm. Bowel Dis."},{"key":"59354_CR2","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","volume":"389","author":"R Ungaro","year":"2017","unstructured":"Ungaro, R., Mehandru, S., Allen, P. B., Peyrin-Biroulet, L. & Colombel, J. F. Ulcerative colitis. Lancet 389, 1756\u20131770 (2017).","journal-title":"Lancet"},{"key":"59354_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","volume":"6","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi, T. et al. Ulcerative colitis. Nat. Rev. Dis. Prim. 6, 74 (2020).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"59354_CR4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(23)00966-2","volume":"402","author":"C Le Berre","year":"2023","unstructured":"Le Berre, C., Honap, S. & Peyrin-Biroulet, L. Ulcerative colitis. Lancet 402, 571\u2013584 (2023).","journal-title":"Lancet"},{"key":"59354_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s00384-023-04397-7","volume":"38","author":"B Bokemeyer","year":"2023","unstructured":"Bokemeyer, B., Picker, N., Kromer, D., Rosin, L. & Patel, H. Rates of clinical remission and inadequate response to advanced therapies among patients with ulcerative colitis in Germany. Int J. Colorectal Dis. 38, 116 (2023).","journal-title":"Int J. Colorectal Dis."},{"key":"59354_CR6","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1053\/j.gastro.2021.12.288","volume":"162","author":"C Abraham","year":"2022","unstructured":"Abraham, C., Abreu, M. T. & Turner, J. R. Pattern recognition receptor signaling and cytokine networks in microbial defenses and regulation of intestinal barriers: implications for inflammatory bowel disease. Gastroenterology 162, 1602\u20131616 e1606 (2022).","journal-title":"Gastroenterology"},{"key":"59354_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","volume":"17","author":"A Lavelle","year":"2020","unstructured":"Lavelle, A. & Sokol, H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 17, 223\u2013237 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"59354_CR8","first-page":"w14599","volume":"148","author":"G Rogler","year":"2018","unstructured":"Rogler, G., Biedermann, L. & Scharl, M. New insights into the pathophysiology of inflammatory bowel disease: microbiota, epigenetics and common signalling pathways. Swiss Med. Wkly 148, w14599 (2018).","journal-title":"Swiss Med. Wkly"},{"key":"59354_CR9","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1136\/gutjnl-2012-303954","volume":"62","author":"D Knights","year":"2013","unstructured":"Knights, D., Lassen, K. G. & Xavier, R. J. Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome. Gut 62, 1505\u20131510 (2013).","journal-title":"Gut"},{"key":"59354_CR10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10208","volume":"474","author":"KJ Maloy","year":"2011","unstructured":"Maloy, K. J. & Powrie, F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474, 298\u2013306 (2011).","journal-title":"Nature"},{"key":"59354_CR11","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1056\/NEJMra0804647","volume":"361","author":"C Abraham","year":"2009","unstructured":"Abraham, C. & Cho, J. H. Inflammatory bowel disease. N. Engl. J. Med. 361, 2066\u20132078 (2009).","journal-title":"N. Engl. J. Med."},{"key":"59354_CR12","doi-asserted-by":"publisher","unstructured":"Gilliland, A., Chan, J., De Wolfe, T. J., Yang, H. & Vallance, B. A. Pathobionts in inflammatory bowel disease: origins, underlying mechanisms, and implications for clinical care. Gastroenterology, https:\/\/doi.org\/10.1053\/j.gastro.2023.09.019 (2023).","DOI":"10.1053\/j.gastro.2023.09.019"},{"key":"59354_CR13","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nm.4517","volume":"24","author":"JA Gilbert","year":"2018","unstructured":"Gilbert, J. A. et al. Current understanding of the human microbiome. Nat. Med. 24, 392\u2013400 (2018).","journal-title":"Nat. Med."},{"key":"59354_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41579-018-0112-2","volume":"17","author":"M Toyofuku","year":"2019","unstructured":"Toyofuku, M., Nomura, N. & Eberl, L. Types and origins of bacterial membrane vesicles. Nat. Rev. Microbiol. 17, 13\u201324 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"59354_CR15","doi-asserted-by":"publisher","unstructured":"Toyofuku, M., Schild, S., Kaparakis-Liaskos, M. & Eberl, L. Composition and functions of bacterial membrane vesicles. Nat. Rev. Microbiol. https:\/\/doi.org\/10.1038\/s41579-023-00875-5 (2023).","DOI":"10.1038\/s41579-023-00875-5"},{"key":"59354_CR16","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri3837","volume":"15","author":"M Kaparakis-Liaskos","year":"2015","unstructured":"Kaparakis-Liaskos, M. & Ferrero, R. L. Immune modulation by bacterial outer membrane vesicles. Nat. Rev. Immunol. 15, 375\u2013387 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"59354_CR17","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S0016-5107(03)02875-X","volume":"59","author":"A Rostom","year":"2004","unstructured":"Rostom, A. & Jolicoeur, E. Validation of a new scale for the assessment of bowel preparation quality. Gastrointest. Endosc. 59, 482\u2013486 (2004).","journal-title":"Gastrointest. Endosc."},{"key":"59354_CR18","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1007\/s10620-022-07530-8","volume":"67","author":"A Kumar","year":"2022","unstructured":"Kumar, A. et al. Endoscopic disease activity and biologic therapy are independent predictors of suboptimal bowel preparation in patients with inflammatory bowel disease undergoing colonoscopy. Dig. Dis. Sci. 67, 4851\u20134865 (2022).","journal-title":"Dig. Dis. Sci."},{"key":"59354_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh, J. A. et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J. Extracell. Vesicles 13, e12404 (2024).","journal-title":"J. Extracell. Vesicles"},{"key":"59354_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12208","volume":"11","author":"EJ Northrop-Albrecht","year":"2022","unstructured":"Northrop-Albrecht, E. J., Taylor, W. R., Huang, B. Q., Kisiel, J. B. & Lucien, F. Assessment of extracellular vesicle isolation methods from human stool supernatant. J. Extracell. Vesicles 11, e12208 (2022).","journal-title":"J. Extracell. Vesicles"},{"key":"59354_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.667987","volume":"11","author":"N Kameli","year":"2021","unstructured":"Kameli, N., Borman, R., Lpez-Iglesias, C., Savelkoul, P. & Stassen, F. R. M. Characterization of Feces-Derived bacterial membrane vesicles and the impact of their origin on the inflammatory response. Front. Cell Infect. Microbiol. 11, 667987 (2021).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"59354_CR22","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.bbadis.2016.10.024","volume":"1863","author":"J Wu","year":"2017","unstructured":"Wu, J., Wang, Y. & Li, L. Functional significance of exosomes applied in sepsis: a novel approach to therapy. Biochim. Biophys. Acta Mol. Basis Dis. 1863, 292\u2013297 (2017).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"59354_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.rmed.2017.04.014","volume":"132","author":"DBA Tan","year":"2017","unstructured":"Tan, D. B. A. et al. Elevated levels of circulating exosome in COPD patients are associated with systemic inflammation. Respir. Med. 132, 261\u2013264 (2017).","journal-title":"Respir. Med."},{"key":"59354_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2022.107983","volume":"59","author":"L Debbi","year":"2022","unstructured":"Debbi, L., Guo, S., Safina, D. & Levenberg, S. Boosting extracellular vesicle secretion. Biotechnol. Adv. 59, 107983 (2022).","journal-title":"Biotechnol. Adv."},{"key":"59354_CR25","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.2147\/IJN.S407029","volume":"18","author":"YG Yuan","year":"2023","unstructured":"Yuan, Y. G. et al. Biogenesis, composition and potential therapeutic applications of mesenchymal stem cells derived exosomes in various diseases. Int. J. Nanomed. 18, 3177\u20133210 (2023).","journal-title":"Int. J. Nanomed."},{"key":"59354_CR26","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1099\/jmm.0.000510","volume":"66","author":"W Abate","year":"2017","unstructured":"Abate, W., Sattar, A. A., Liu, J., Conway, M. E. & Jackson, S. K. Evaluation of recombinant factor C assay for the detection of divergent lipopolysaccharide structural species and comparison with Limulus amebocyte lysate-based assays and a human monocyte activity assay. J. Med. Microbiol. 66, 888\u2013897 (2017).","journal-title":"J. Med. Microbiol."},{"key":"59354_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-69983-z","volume":"10","author":"N Yoshida","year":"2020","unstructured":"Yoshida, N. et al. A possible beneficial effect of Bacteroides on faecal lipopolysaccharide activity and cardiovascular diseases. Sci. Rep. 10, 13009 (2020).","journal-title":"Sci. Rep."},{"key":"59354_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41596-019-0236-5","volume":"15","author":"J Tulkens","year":"2020","unstructured":"Tulkens, J., De Wever, O. & Hendrix, A. Analyzing bacterial extracellular vesicles in human body fluids by orthogonal biophysical separation and biochemical characterization. Nat. Protoc. 15, 40\u201367 (2020).","journal-title":"Nat. Protoc."},{"key":"59354_CR29","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1097\/01.meg.0000108346.41221.19","volume":"16","author":"LA van der Waaij","year":"2004","unstructured":"van der Waaij, L. A. et al. Immunoglobulin coating of faecal bacteria in inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 16, 669\u2013674 (2004).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"59354_CR30","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.cell.2014.08.006","volume":"158","author":"NW Palm","year":"2014","unstructured":"Palm, N. W. et al. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 158, 1000\u20131010 (2014).","journal-title":"Cell"},{"key":"59354_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1723-0","volume":"16","author":"R Lin","year":"2018","unstructured":"Lin, R. et al. Clinical significance of soluble immunoglobulins A and G and their coated bacteria in feces of patients with inflammatory bowel disease. J. Transl. Med. 16, 359 (2018).","journal-title":"J. Transl. Med."},{"key":"59354_CR32","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.immuni.2019.02.006","volume":"50","author":"T Castro-Dopico","year":"2019","unstructured":"Castro-Dopico, T. et al. Anti-commensal IgG Drives Intestinal Inflammation and Type 17 Immunity in Ulcerative Colitis. Immunity 50, 1099\u20131114.e1010 (2019).","journal-title":"Immunity"},{"key":"59354_CR33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/gut.38.3.365","volume":"38","author":"A Macpherson","year":"1996","unstructured":"Macpherson, A., Khoo, U. Y., Forgacs, I., Philpott-Howard, J. & Bjarnason, I. Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria. Gut 38, 365\u2013375 (1996).","journal-title":"Gut"},{"key":"59354_CR34","doi-asserted-by":"crossref","unstructured":"Monteiro, R. C. & Van De Winkel, J. G. IgA Fc receptors. Annu. Rev. Immunol. 21, 177\u2013204, (2003).","DOI":"10.1146\/annurev.immunol.21.120601.141011"},{"key":"59354_CR35","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s00018-018-2976-8","volume":"76","author":"IS Hansen","year":"2019","unstructured":"Hansen, I. S., Baeten, D. L. P. & den Dunnen, J. The inflammatory function of human IgA. Cell Mol. Life Sci. 76, 1041\u20131055 (2019).","journal-title":"Cell Mol. Life Sci."},{"key":"59354_CR36","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2147\/ITT.S266242","volume":"9","author":"MMJ van Gool","year":"2020","unstructured":"van Gool, M. M. J. & van Egmond, M. IgA and FcalphaRI: versatile players in homeostasis, infection, and autoimmunity. Immunotargets Ther. 9, 351\u2013372 (2020).","journal-title":"Immunotargets Ther."},{"key":"59354_CR37","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3389\/fimmu.2019.00553","volume":"10","author":"A Breedveld","year":"2019","unstructured":"Breedveld, A. & van Egmond, M. IgA and FcalphaRI: pathological roles and therapeutic opportunities. Front. Immunol. 10, 553 (2019).","journal-title":"Front. Immunol."},{"key":"59354_CR38","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1084\/jem.20112005","volume":"209","author":"L Berthelot","year":"2012","unstructured":"Berthelot, L. et al. Transglutaminase is essential for IgA nephropathy development acting through IgA receptors. J. Exp. Med. 209, 793\u2013806 (2012).","journal-title":"J. Exp. Med."},{"key":"59354_CR39","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1084\/jem.191.11.1999","volume":"191","author":"P Launay","year":"2000","unstructured":"Launay, P. et al. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger\u2019s disease) evidence for pathogenic soluble receptor-Iga complexes patients and CD89 transgenic mice.J. Exp. Med. 191, 1999\u20132009 (2000).","journal-title":"J. Exp. Med."},{"key":"59354_CR40","first-page":"1579","volume":"33","author":"L Berthelot","year":"2018","unstructured":"Berthelot, L. et al. Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort. Nephrol. Dialysis Transplant. 33, 1579\u20131590 (2018).","journal-title":"Nephrol. Dialysis Transplant."},{"key":"59354_CR41","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.4049\/jimmunol.167.5.2651","volume":"167","author":"PD Smith","year":"2001","unstructured":"Smith, P. D. et al. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J. Immunol. 167, 2651\u20132656 (2001).","journal-title":"J. Immunol."},{"key":"59354_CR42","doi-asserted-by":"publisher","unstructured":"Wera, O., Lancellotti, P. & Oury, C. The dual role of neutrophils in inflammatory bowel diseases. J. Clin. Med. 5, https:\/\/doi.org\/10.3390\/jcm5120118 (2016).","DOI":"10.3390\/jcm5120118"},{"key":"59354_CR43","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cellimm.2014.03.012","volume":"291","author":"CC Bain","year":"2014","unstructured":"Bain, C. C. & Mowat, A. M. The monocyte-macrophage axis in the intestine. Cell Immunol. 291, 41\u201348 (2014).","journal-title":"Cell Immunol."},{"key":"59354_CR44","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1053\/j.gastro.2009.06.047","volume":"137","author":"L van der Steen","year":"2009","unstructured":"van der Steen, L. et al. Immunoglobulin A: Fc(alpha)RI interactions induce neutrophil migration through release of leukotriene B4. Gastroenterology 137, 2018\u20132029.e2011-2013 (2009).","journal-title":"Gastroenterology"},{"key":"59354_CR45","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.4049\/jimmunol.164.10.5029","volume":"164","author":"T Kitamura","year":"2000","unstructured":"Kitamura, T. et al. Human intestinal epithelial cells express a novel receptor for IgA. J. Immunol. 164, 5029\u20135034 (2000).","journal-title":"J. Immunol."},{"key":"59354_CR46","doi-asserted-by":"publisher","first-page":"24315","DOI":"10.1074\/jbc.M107057200","volume":"277","author":"D Iwaki","year":"2002","unstructured":"Iwaki, D. et al. The extracellular toll-like receptor 2 domain directly binds peptidoglycan derived from Staphylococcus aureus. J. Biol. Chem. 277, 24315\u201324320 (2002).","journal-title":"J. Biol. Chem."},{"key":"59354_CR47","doi-asserted-by":"publisher","first-page":"17406","DOI":"10.1074\/jbc.274.25.17406","volume":"274","author":"R Schwandner","year":"1999","unstructured":"Schwandner, R., Dziarski, R., Wesche, H., Rothe, M. & Kirschning, C. J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 274, 17406\u201317409 (1999).","journal-title":"J. Biol. Chem."},{"key":"59354_CR48","first-page":"43","volume":"2","author":"G Reuter","year":"2001","unstructured":"Reuter, G. The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession. Curr. Issues Intest. Microbiol. 2, 43\u201353 (2001).","journal-title":"Curr. Issues Intest. Microbiol."},{"key":"59354_CR49","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1128\/CMR.00008-07","volume":"20","author":"HM Wexler","year":"2007","unstructured":"Wexler, H. M. Bacteroides: the good, the bad, and the nitty-gritty. Clin. Microbiol. Rev. 20, 593\u2013621 (2007).","journal-title":"Clin. Microbiol. Rev."},{"key":"59354_CR50","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01115-23","volume":"11","author":"HB Thapa","year":"2023","unstructured":"Thapa, H. B. et al. Characterization of the inflammatory response evoked by bacterial membrane vesicles in intestinal cells reveals an RIPK2-dependent activation by enterotoxigenic Escherichia coli vesicles. Microbiol. Spectr. 11, e0111523 (2023).","journal-title":"Microbiol. Spectr."},{"key":"59354_CR51","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s41385-019-0167-z","volume":"12","author":"S Koernig","year":"2019","unstructured":"Koernig, S. et al. Topical application of human-derived Ig isotypes for the control of acute respiratory infection evaluated in a human CD89-expressing mouse model. Mucosal Immunol. 12, 1013\u20131024 (2019).","journal-title":"Mucosal Immunol."},{"key":"59354_CR52","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/jgh.13598","volume":"32","author":"S Thorsvik","year":"2017","unstructured":"Thorsvik, S. et al. Fecal neutrophil gelatinase-associated lipocalin as a biomarker for inflammatory bowel disease. J. Gastroenterol. Hepatol. 32, 128\u2013135 (2017).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"59354_CR53","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s12026-022-09352-2","volume":"71","author":"S Asaf","year":"2023","unstructured":"Asaf, S. et al. Lipocalin 2-not only a biomarker: a study of current literature and systematic findings of ongoing clinical trials. Immunol. Res. 71, 287\u2013313 (2023).","journal-title":"Immunol. Res."},{"key":"59354_CR54","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000515","author":"J Stallhofer","year":"2015","unstructured":"Stallhofer, J. et al. Lipocalin-2 is a disease activity marker in inflammatory bowel disease regulated by IL-17A, IL-22, and TNF-alpha and Modulated by IL23R genotype status. Inflamm. Bowel Dis. https:\/\/doi.org\/10.1097\/MIB.0000000000000515 (2015).","journal-title":"Inflamm. Bowel Dis."},{"key":"59354_CR55","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/nri3322","volume":"12","author":"O Pabst","year":"2012","unstructured":"Pabst, O. New concepts in the generation and functions of IgA. Nat. Rev. Immunol. 12, 821\u2013832 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"59354_CR56","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fimmu.2012.00100","volume":"3","author":"E Slack","year":"2012","unstructured":"Slack, E., Balmer, M. L., Fritz, J. H. & Hapfelmeier, S. Functional flexibility of intestinal IgA - broadening the fine line. Front. Immunol. 3, 100 (2012).","journal-title":"Front. Immunol."},{"key":"59354_CR57","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.chom.2020.12.003","volume":"29","author":"JM Shapiro","year":"2021","unstructured":"Shapiro, J. M. et al. Immunoglobulin A targets a unique subset of the microbiota in inflammatory bowel disease. Cell Host Microbe 29, 83\u201393 e83 (2021).","journal-title":"Cell Host Microbe"},{"key":"59354_CR58","doi-asserted-by":"publisher","unstructured":"Thapa, H. B., Ebenberger, S. P. & Schild, S. The two faces of bacterial membrane vesicles: pathophysiological roles and therapeutic opportunities. Antibiotics 12, https:\/\/doi.org\/10.3390\/antibiotics12061045 (2023).","DOI":"10.3390\/antibiotics12061045"},{"key":"59354_CR59","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrmicro2384","volume":"8","author":"RA Strugnell","year":"2010","unstructured":"Strugnell, R. A. & Wijburg, O. L. The role of secretory antibodies in infection immunity. Nat. Rev. Microbiol. 8, 656\u2013667 (2010).","journal-title":"Nat. Rev. Microbiol."},{"key":"59354_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03318-5","volume":"9","author":"IS Hansen","year":"2018","unstructured":"Hansen, I. S. et al. FcalphaRI co-stimulation converts human intestinal CD103(+) dendritic cells into pro-inflammatory cells through glycolytic reprogramming. Nat. Commun. 9, 863 (2018).","journal-title":"Nat. Commun."},{"key":"59354_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.828704","volume":"13","author":"DN Villageliu","year":"2022","unstructured":"Villageliu, D. N. & Samuelson, D. R. The role of bacterial membrane vesicles in human health and disease. Front. Microbiol. 13, 828704 (2022).","journal-title":"Front. Microbiol."},{"key":"59354_CR62","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1136\/gut.2010.225482","volume":"60","author":"K Leiper","year":"2011","unstructured":"Leiper, K. et al. Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis. Gut 60, 1520\u20131526 (2011).","journal-title":"Gut"},{"key":"59354_CR63","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41591-022-01680-y","volume":"28","author":"M Uzzan","year":"2022","unstructured":"Uzzan, M. et al. Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity. Nat. Med. 28, 766\u2013779 (2022).","journal-title":"Nat. Med."},{"key":"59354_CR64","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1093\/ibd\/izad024","volume":"29","author":"G Bamias","year":"2023","unstructured":"Bamias, G., Kitsou, K. & Rivera-Nieves, J. The underappreciated role of secretory IgA in IBD. Inflamm. Bowel Dis. 29, 1327\u20131341 (2023).","journal-title":"Inflamm. Bowel Dis."},{"key":"59354_CR65","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","volume":"13","author":"C Maaser","year":"2019","unstructured":"Maaser, C. et al. ECCO-ESGAR guideline for diagnostic assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications. J. Crohns Colitis 13, 144\u2013164 (2019).","journal-title":"J. Crohns Colitis"},{"key":"59354_CR66","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/ecco-jcc\/jjy114","volume":"13","author":"A Sturm","year":"2019","unstructured":"Sturm, A. et al. ECCO-ESGAR guideline for diagnostic assessment in IBD Part 2: IBD scores and general principles and technical aspects. J. Crohns Colitis 13, 273\u2013284 (2019).","journal-title":"J. Crohns Colitis"},{"key":"59354_CR67","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","volume":"317","author":"KW Schroeder","year":"1987","unstructured":"Schroeder, K. W., Tremaine, W. J. & Ilstrup, D. M. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. N. Engl. J. Med. 317, 1625\u20131629 (1987).","journal-title":"N. Engl. J. Med."},{"key":"59354_CR68","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/ajg.2015.233","volume":"110","author":"L Peyrin-Biroulet","year":"2015","unstructured":"Peyrin-Biroulet, L. et al. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target. Am. J. Gastroenterol. 110, 1324\u20131338 (2015).","journal-title":"Am. J. Gastroenterol."},{"key":"59354_CR69","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gut.2005.082909","volume":"55","author":"J Satsangi","year":"2006","unstructured":"Satsangi, J., Silverberg, M. S., Vermeire, S. & Colombel, J. F. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55, 749\u2013753 (2006).","journal-title":"Gut"},{"key":"59354_CR70","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1182\/blood-2006-05-022954","volume":"109","author":"A Jorgl","year":"2007","unstructured":"Jorgl, A. et al. Human Langerhans-cell activation triggered in vitro by conditionally expressed MKK6 is counterregulated by the downstream effector RelB. Blood 109, 185\u2013193 (2007).","journal-title":"Blood"},{"key":"59354_CR71","unstructured":"Bio-Rad. Bio-Rad Protein Assay https:\/\/www.bio-rad.com\/de-at\/product\/bio-rad-protein-assay?ID=d4d4169a-12e8-4819-8b3e-ccab019c6e13 (2024)."},{"key":"59354_CR72","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/1751-7915.13572","volume":"13","author":"S Hirayama","year":"2020","unstructured":"Hirayama, S. & Nakao, R. Glycine significantly enhances bacterial membrane vesicle production: a powerful approach for isolation of LPS-reduced membrane vesicles of probiotic Escherichia coli. Micro. Biotechnol. 13, 1162\u20131178 (2020).","journal-title":"Micro. Biotechnol."},{"key":"59354_CR73","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1128\/JB.00498-06","volume":"188","author":"AJ McBroom","year":"2006","unstructured":"McBroom, A. J., Johnson, A. P., Vemulapalli, S. & Kuehn, M. J. Outer membrane vesicle production by Escherichia coli is independent of membrane instability. J. Bacteriol. 188, 5385\u20135392 (2006).","journal-title":"J. Bacteriol."},{"key":"59354_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10515","volume":"7","author":"S Roier","year":"2016","unstructured":"Roier, S. et al. A novel mechanism for the biogenesis of outer membrane vesicles in Gram-negative bacteria. Nat. Commun. 7, 10515 (2016).","journal-title":"Nat. Commun."},{"key":"59354_CR75","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.3389\/fmicb.2019.02780","volume":"10","author":"D Vorkapic","year":"2019","unstructured":"Vorkapic, D. et al. A broad spectrum protein glycosylation system influences type II protein secretion and associated phenotypes in vibrio cholerae. Front. Microbiol. 10, 2780 (2019).","journal-title":"Front. Microbiol."},{"key":"59354_CR76","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/nmeth.1322","volume":"6","author":"JR Wisniewski","year":"2009","unstructured":"Wisniewski, J. R., Zougman, A., Nagaraj, N. & Mann, M. Universal sample preparation method for proteome analysis. Nat. Methods 6, 359\u2013362 (2009).","journal-title":"Nat. Methods"},{"key":"59354_CR77","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1021\/ac026117i","volume":"75","author":"J Rappsilber","year":"2003","unstructured":"Rappsilber, J., Ishihama, Y. & Mann, M. Stop and go extraction tips for matrix-assisted laser desorption\/ionization, nanoelectrospray, and LC\/MS sample pretreatment in proteomics. Anal. Chem. 75, 663\u2013670 (2003).","journal-title":"Anal. Chem."},{"key":"59354_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/1751-0473-8-3","volume":"8","author":"S Barkow-Oesterreicher","year":"2013","unstructured":"Barkow-Oesterreicher, S., Turker, C. & Panse, C. FCC - An automated rule-based processing tool for life science data. Source Code Biol. Med. 8, 3 (2013).","journal-title":"Source Code Biol. Med."},{"key":"59354_CR79","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","volume":"141","author":"T Sato","year":"2011","unstructured":"Sato, T. et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett\u2019s epithelium. Gastroenterology 141, 1762\u20131772 (2011).","journal-title":"Gastroenterology"},{"key":"59354_CR80","doi-asserted-by":"publisher","unstructured":"Busslinger, G. A. et al. Molecular characterization of Barrett\u2019s esophagus at single-cell resolution. Proc. Natl. Acad. Sci. USA 118, https:\/\/doi.org\/10.1073\/pnas.2113061118 (2021).","DOI":"10.1073\/pnas.2113061118"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59354-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59354-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59354-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T10:03:51Z","timestamp":1745921031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59354-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["59354"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-59354-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"1 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3995"}}